Latest Funding Risk News

Astral Resources has secured a fully-funded joint venture with Mineral Mining Services to accelerate early gold production at its Think Big Gold Project near Kalgoorlie, promising reduced funding risks and faster cash flow.

Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.

Mont Royal Resources Ltd has lodged a replacement prospectus to raise between A$8 million and A$10 million, supporting its merger with Commerce Resources Corp and advancing critical minerals projects in Quebec, Canada.

West Wits Mining has locked in a USD 12.5 million tranche of a USD 35 million loan facility from Nebari to accelerate development of its Qala Shallows Gold Project, aiming for first gold production in early 2026.

Adavale Resources has launched an offer of over 82 million new options following recent placements that raised approximately $3.1 million. These options, exercisable at $0.035 each, aim to reward investors, directors, and the lead manager while potentially raising further capital.

Kuniko Limited has launched a partially underwritten rights issue to fund exploration at its Commonwealth Gold-Silver Project in New South Wales, aiming to capitalise on high-grade multi-metal potential in a Tier-1 jurisdiction.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Spenda Limited reported a 106% surge in revenue to $11.1 million for FY25, driven by acquisitions and expanded services, yet posted a substantial $24.3 million net loss largely due to goodwill impairment. The company’s strategic moves and funding needs highlight a pivotal phase ahead.

KneoMedia has narrowed its FY25 net loss by 38%, driven by cost controls and a strategic shift to its scalable KneoScience EdTech platform. The company also secured a $700,000 order for FY26, signaling growing traction in the US education market.

Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.